aberrations.112 Lastly, the choice BTK inhibitor acalabrutinib was a short while ago approved via the FDA (not because of the EMA nevertheless) as frontline therapy in look at of the outcomes of the stage III demo comparing acalabrutinib as opposed to????? ?? ?? ? ??? ????????????? ????????????????? ???????????????????Richter transformation stays a